NRXS
NeurAxis, Inc.
NYSE AmericanUSDEQUITY
Healthcare
DELAYED
Buy
+31/100
Last price
6.78
▼ 0.37 (5.17%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
7.15
Day high
7.31
Day low
6.76
Volume
66.52K
Market cap
$85.14M
P/E (TTM)
—
52W range
2.21 – 9.33
Trailing performance
Returnvs SPY
1W
-12.63%
-14.6%
1M
+13.76%
+12.6%
3M
-4.24%
-8.8%
6M
-7.63%
-25.8%
YTD
+49.34%
+35.1%
1Y
+113.21%
+96.8%
3Y
+78.42%
-3.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NRXS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.18M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 24, 26 | CARRICO THOMAS JOESEPH Officer |
CONVERSION | 306.24K | $2.13M | Direct |
| Aug 24, 26 | CARRICO BRIAN ALLEN Chief Executive Officer |
CONVERSION | 320.00K | $2.22M | Direct |
| Aug 24, 26 | MIRANDA ADRIAN Officer |
CONVERSION | 337.20K | $2.34M | Direct |
| Aug 24, 26 | CARRICO THOMAS JOESEPH Officer |
STOCK | 193.68K | $0 | Direct |
| Aug 24, 26 | CARRICO BRIAN ALLEN Chief Executive Officer |
STOCK | 199.19K | $0 | Direct |
| Aug 24, 26 | MIRANDA ADRIAN Officer |
STOCK | 199.11K | $0 | Direct |
| Aug 13, 26 | FERGE KRISTIN A Director |
STOCK | 31.13K | $195.52K | Direct |
| Aug 13, 26 | AHARON GILAD S. Director |
STOCK | 86.22K | $275.88K | |
| Aug 13, 26 | WATKINS BRADLEY MITCHELL Director |
STOCK | 26.07K | $163.74K | Direct |
| Aug 13, 26 | KEYSER JANE ELIZABETH Director |
STOCK | 26.07K | $163.74K | Direct |
| Apr 28, 26 | AHARON GILAD S. Director |
STOCK | 234.22K | $0 | |
| Apr 1, 26 | CARRICO THOMAS JOESEPH Officer |
BUY | 667 | $4.79K | Direct |
| Apr 1, 26 | CARRICO BRIAN ALLEN Chief Executive Officer |
BUY | 8.06K | $57.87K | Direct |
| Apr 1, 26 | HENRICHS TIMOTHY ROBERT Chief Financial Officer |
BUY | 7.59K | $54.52K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AHARON GILAD S. |
Director | — | Stock Award(Grant) |
CARRICO BRIAN ALLEN |
Chief Executive Officer | 227.34K | Conversion of Exercise of derivative security |
CARRICO THOMAS JOESEPH |
Officer | 199.34K | Conversion of Exercise of derivative security |
FERGE KRISTIN A |
Director | 67.07K | Stock Award(Grant) |
HANNASCH BRIAN |
Beneficial Owner of more than 10% of a Class of Security | 1.21M | Purchase |
HENRICHS TIMOTHY ROBERT |
Chief Financial Officer | 7.59K | Purchase |
KEYSER JANE ELIZABETH |
Director | 72.41K | Stock Award(Grant) |
MASIMO CORP. |
Beneficial Owner of more than 10% of a Class of Security | 0 | Conversion of Exercise of derivative security |
MIRANDA ADRIAN |
Officer | 199.11K | Conversion of Exercise of derivative security |
WATKINS BRADLEY MITCHELL |
Director | 72.41K | Stock Award(Grant) |
Fundamentals
Market cap$85.14M
Enterprise value$77.10M
Revenue (TTM)$5.32M
Gross profit$4.55M
EBITDA$-7.61M
Net income$-8.45M
EPS (TTM)$-0.78
Free cash flow$-3.15M
Total cash$8.32M
Total debt$279.39K
Book value / share$0.54
Shares outstanding12.56M
Float8.34M
Short % of float3.84%
Dividend yield0.00%
Beta (5Y)1.37
Valuation & profitability ratios
Trailing P/E—
Forward P/E-25.11
PEG ratio—
Price / sales—
Price / book12.56
EV / revenue14.50
EV / EBITDA-10.13
Gross margin85.56%
Operating margin-110.16%
Profit margin-144.44%
Return on equity-139.76%
Return on assets-56.21%
Debt / equity4.15
Current ratio3.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.57M | $2.69M | $2.46M | $2.68M | +32.9% |
| Operating revenue | $3.57M | $2.69M | $2.46M | $2.68M | +32.9% |
| Cost of revenue | $562.92K | $362.00K | $303.35K | $297.06K | +55.5% |
| Gross profit | $3.01M | $2.32M | $2.16M | $2.39M | +29.4% |
| Research & development | $493.61K | $433.61K | $169.31K | $225.61K | +13.8% |
| Selling, general & admin | $10.34M | $9.05M | $8.65M | $5.53M | +14.3% |
| Total operating expense | $10.84M | $9.48M | $8.82M | $5.76M | +14.3% |
| Operating income | -$7.83M | -$7.16M | -$6.66M | -$3.37M | -9.4% |
| Net interest income | -$104.21K | -$531.54K | -$5.36M | -$2.74M | +80.4% |
| Pre-tax income | -$7.80M | -$8.24M | -$14.63M | -$4.78M | +5.4% |
| Net income | -$7.80M | -$8.24M | -$14.63M | -$4.78M | +5.4% |
| Net income to common | -$8.62M | -$8.45M | -$14.63M | -$5.54M | -1.9% |
| Basic EPS | -0.95 | -1.22 | -2.25 | -0.90 | +22.1% |
| Diluted EPS | -0.95 | -1.22 | -2.25 | -0.90 | +22.1% |
| EBIT | -$7.73M | -$7.94M | -$9.27M | -$4.36M | +2.7% |
| EBITDA | -$7.67M | -$7.90M | -$9.23M | -$4.33M | +3.0% |
| Basic shares | 9.08M | 6.92M | 6.51M | 6.14M | +31.3% |
| Diluted shares | 9.08M | 6.92M | 6.51M | 8.41M | +31.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.97M | $3.70M | $78.56K | $253.70K | — | +34.3% |
| Cash & short-term investments | $4.97M | $3.70M | $78.56K | $253.70K | — | +34.3% |
| Accounts receivable | $195.70K | $244.62K | $73.17K | $174.40K | — | -20.0% |
| Inventory | $257.13K | $44.33K | $21.22K | $48.13K | — | +480.1% |
| Total current assets | $5.73M | $4.27M | $242.61K | $476.96K | — | +34.4% |
| Property, plant & equipment | $337.13K | $374.64K | $158.81K | $189.39K | — | -10.0% |
| Goodwill & intangibles | $274.78K | $96.59K | $108.07K | $77.56K | — | +184.5% |
| Total assets | $6.40M | $4.76M | $509.50K | $1.48M | — | +34.6% |
| Total current liabilities | $2.79M | $2.43M | $1.89M | $6.98M | — | +14.7% |
| Current debt | $148.29K | $154.15K | $148.06K | $489.23K | — | -3.8% |
| Long-term debt | — | — | — | — | $51.69K | — |
| Total debt | $416.61K | $473.40K | $224.26K | $598.82K | — | -12.0% |
| Total liabilities | $3.00M | $2.69M | $1.91M | $7.05M | — | +11.7% |
| Retained earnings | -$64.60M | -$56.80M | -$48.56M | -$33.93M | — | -13.7% |
| Shareholder equity | $3.40M | $2.07M | -$1.40M | -$5.57M | — | +64.4% |
| Working capital | $2.94M | $1.83M | -$1.64M | -$6.50M | — | +60.5% |
| Net tangible assets | $3.12M | $1.97M | -$1.51M | -$5.65M | — | +58.5% |
| Shares issued | 10.65M | 6.99M | 6.51M | 6.04M | — | +52.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$7.80M | -$8.24M | -$14.63M | -$4.78M | +5.4% |
| Depreciation & amortisation | $59.50K | $37.83K | $40.73K | $37.13K | +57.3% |
| Stock-based compensation | $596.85K | $1.40M | $750.00K | $27.32K | -57.5% |
| Change in working capital | $610.12K | $141.40K | -$665.75K | $1.27M | +331.5% |
| Operating cash flow | -$6.43M | -$6.10M | -$6.69M | -$2.30M | -5.5% |
| Capital expenditure | -$131.15K | -$27.78K | -$71.78K | -$61.20K | -372.2% |
| Investing cash flow | -$131.15K | -$27.78K | -$71.78K | -$61.20K | -372.2% |
| Financing cash flow | $7.83M | $9.74M | $6.59M | $2.29M | -19.6% |
| Free cash flow | -$6.56M | -$6.13M | -$6.77M | -$2.36M | -7.1% |
| End cash position | $4.97M | $3.70M | $78.56K | $253.70K | +34.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.93M | $1.61M | $968.13K | $811.41K | $894.09K | — | +20.0% |
| Operating revenue | $1.93M | $1.61M | $968.13K | $811.41K | $894.09K | — | +20.0% |
| Cost of revenue | $272.57K | $218.37K | $141.65K | $135.49K | $146.64K | — | +24.8% |
| Gross profit | $1.66M | $1.39M | $826.48K | $675.93K | $747.44K | — | +19.2% |
| Research & development | $274.34K | $99.57K | $146.18K | $130.85K | $115.20K | — | +175.5% |
| Selling, general & admin | $3.51M | $3.03M | $2.40M | $2.65M | $2.35M | — | +15.7% |
| Total operating expense | $3.78M | $3.13M | $2.54M | $2.78M | $2.47M | — | +20.8% |
| Operating income | -$2.12M | -$1.74M | -$1.72M | -$2.10M | -$1.72M | — | -22.1% |
| Net interest income | -$19.79K | -$26.19K | -$28.64K | -$59.90K | -$13.43K | — | +24.4% |
| Pre-tax income | -$2.09M | -$1.76M | -$1.71M | -$2.12M | -$1.69M | — | -18.4% |
| Net income | -$2.09M | -$1.76M | -$1.71M | -$2.12M | -$1.69M | — | -18.4% |
| Net income to common | -$2.28M | -$1.95M | -$1.90M | -$2.32M | -$1.90M | — | -16.7% |
| Basic EPS | -0.19 | -0.18 | — | -0.24 | -0.22 | -0.33 | -5.6% |
| Diluted EPS | -0.19 | -0.18 | — | -0.24 | -0.22 | -0.33 | -5.6% |
| EBIT | -$2.07M | -$1.74M | -$1.68M | -$2.09M | -$1.68M | — | -19.1% |
| EBITDA | -$2.05M | -$1.72M | -$1.66M | -$2.08M | -$1.66M | — | -19.2% |
| Basic shares | 12.12M | 10.95M | — | 9.88M | 8.52M | 7.46M | +10.7% |
| Diluted shares | 12.12M | 10.95M | — | 9.88M | 8.52M | 7.46M | +10.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.32M | $7.08M | $4.97M | $4.38M | $5.99M | +17.6% |
| Cash & short-term investments | $8.32M | $7.08M | $4.97M | $4.38M | $5.99M | +17.6% |
| Accounts receivable | $432.93K | $385.01K | $195.70K | $108.50K | $128.52K | +12.4% |
| Inventory | $277.31K | $238.28K | $257.13K | $110.26K | $131.43K | +16.4% |
| Total current assets | $9.41M | $8.14M | $5.73M | $4.99M | $6.62M | +15.6% |
| Property, plant & equipment | $294.01K | $312.88K | $337.13K | $362.69K | $357.76K | -6.0% |
| Goodwill & intangibles | $258.21K | $266.49K | $274.78K | $311.54K | $91.34K | -3.1% |
| Total assets | $10.00M | $8.75M | $6.40M | $5.78M | $7.09M | +14.3% |
| Total current liabilities | $3.10M | $2.81M | $2.79M | $3.15M | $2.35M | +10.0% |
| Current debt | $42.73K | $100.73K | $148.29K | $195.66K | $121.43K | -57.6% |
| Total debt | $279.39K | $353.52K | $416.61K | $478.43K | $410.48K | -21.0% |
| Total liabilities | $3.26M | $3.00M | $3.00M | $3.49M | $2.83M | +8.8% |
| Retained earnings | -$69.66M | -$66.36M | -$64.60M | -$62.89M | -$60.77M | -5.0% |
| Shareholder equity | $6.74M | $5.75M | $3.40M | $2.28M | $4.25M | +17.2% |
| Working capital | $6.32M | $5.33M | $2.94M | $1.84M | $4.27M | +18.6% |
| Net tangible assets | $6.48M | $5.48M | $3.12M | $1.97M | $4.16M | +18.2% |
| Shares issued | 12.48M | 11.45M | 10.65M | 9.89M | 9.86M | +9.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$2.09M | -$1.76M | -$1.71M | -$2.12M | -$1.69M | — | -18.4% |
| Depreciation & amortisation | $16.65K | $16.32K | $24.05K | $16.20K | $12.88K | — | +2.0% |
| Stock-based compensation | $689.80K | $379.44K | $157.68K | $160.32K | $173.04K | — | +81.8% |
| Change in working capital | $311.75K | $94.78K | -$436.36K | $485.24K | $10.79K | — | +228.9% |
| Operating cash flow | -$1.03M | -$1.23M | -$1.93M | -$1.43M | -$1.47M | — | +16.3% |
| Capital expenditure | — | — | -$105.86K | — | -$7.29K | -$18.00K | — |
| Investing cash flow | -$6.30K | $0 | -$105.86K | $0 | -$7.29K | — | — |
| Financing cash flow | $2.28M | $3.34M | $2.63M | -$183.81K | $5.46M | — | -31.8% |
| Free cash flow | -$1.04M | -$1.23M | -$2.04M | -$1.43M | -$1.47M | — | +15.8% |
| End cash position | $8.32M | $7.08M | $4.97M | $4.38M | $5.99M | — | +17.6% |
Options analytics
Put / call volume
3.71
Put-heavy session
Put / call open interest
13.16
Positioning, not flow
Max pain
5.00
-26.3% from spot
ATM implied vol
25.0%
Nearest strike to spot
Skew (10% OTM)
+25.0%
Puts bid over calls
Call volume
14
Contracts, this expiry
Put volume
52
Contracts, this expiry
Heaviest call OI
7.50
35 contracts
Heaviest put OI
5.00
800 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.32 | -0.19 | +40.6% |
| Mar 2026 | -0.19 | — | — |
| Dec 2025 | -0.22 | -0.10 | +53.9% |
| Sep 2025 | -0.20 | -0.24 | -20.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.21 | 1 | $2.10M | +158.8% |
| Next quarter | -0.18 | 1 | $2.60M | +168.6% |
| Current year | -0.76 | 1 | $8.30M | +132.5% |
| Next year | -0.27 | 1 | $19.80M | +138.6% |
Analyst targets & ownership
Mean target$11.00
High target$13.00
Low target$9.00
Implied upside62.24%
Analyst count2
ConsensusNONE
Strong buy / Buy0 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders25.34%
Held by institutions28.44%
Institutions holding38
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
7.34
-7.58% from price
SMA 20
6.93
-2.16% from price
SMA 50
6.55
+3.57% from price
SMA 100
6.81
-0.51% from price
SMA 200
6.39
+6.03% from price
EMA 12
7.13
-4.85% from price
EMA 26
6.91
-1.84% from price
EMA 50
6.77
+0.13% from price
RSI (14)
48.0
Neutral
MACD (12,26,9)
0.22
Hist -0.05
ATR (14)
0.59
8.70% of price
Realised vol 30D
76.1%
Annualised
Bollinger upper
8.41
20, 2σ
Bollinger lower
5.45
20, 2σ
50 / 200 cross
Golden
6.55 vs 6.39
Trend bias
Above 200
+6.03%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.36
More volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
76.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-39.5%
Peak to trough
Max drawdown 5Y
-74.0%
Peak to trough
ATR 14
0.59
8.70% of price
Beta (reported)
1.37
5Y monthly, from filing
Short interest
Shares short
377.07K
Prior 410.75K
Change vs prior
-8.2%
Shorts covering
% of float
3.84%
Normal
% of shares out
3.00%
Against total outstanding
Days to cover
5.5
Crowded exit
Float
8.34M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 20, 26 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Dec 22, 25 | Craig-Hallum | MAINTAINED | Buy | Buy |
| Jun 16, 25 | Craig-Hallum | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-19
Periodic Financial Reports
10-Q · 2026-08-11
Offering Registrations
S-3/A · 2026-07-30
Offering Registrations
S-3 · 2026-07-23
Corporate Changes & Voting Matters
8-K · 2026-07-10
Corporate Changes & Voting Matters
8-K · 2026-06-12
Periodic Financial Reports
10-Q · 2026-05-12
Proxy Statements
DEF 14A · 2026-04-28
Headlines
NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer
GlobeNewswire · 8d ago
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
GlobeNewswire · 21d ago
NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference
GlobeNewswire · 21d ago
Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?
Zacks · 22d ago
iAccess Alpha Virtual Best Ideas Fall Investment Conference Begins Today with Updated Presentation Schedule
ACCESS Newswire · 22d ago
Is Kodak having a "Kodak moment?" 2 watchlist stocks.
Zacks · 25d ago
iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026
ACCESS Newswire · 29d ago
NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up
Zacks · 54d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.